v3.26.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:      
Net income/(loss)   $ 6,411,701 $ (1,791,913)
Adjustments to reconcile net income/(loss) to net cash used in operating activities      
Allocated expense for warrant issuance cost $ 101,971   101,971
Interest income reinvested in the Trust Account   (6,429,691) (2,306,234)
Change in fair value of public warrant liabilities 3,767,400 (1,524,900) 3,767,400
Changes in operating assets and liabilities:      
Prepaid assets   87,455 (540,253)
Accrued expenses, formation and offering costs   999,863 468,087
Net cash used in operating activities   (455,572) (300,942)
Cash flows from investing activities:      
Cash deposited in trust account     (358,800,000)
Cash withdrawn from Trust Account as tax and regulatory withdrawal   30,537  
Net cash provided by/(used in) investing activities   30,537 (358,800,000)
Cash flows from financing activities:      
Proceeds from sale of Units in initial public offering     358,800,000
Proceeds from sale of Private Placement Shares to Sponsor     2,250,000
Deferred offering costs     (461,412)
Payment of accrued offering costs     (746,871)
Payment of underwriters’ discounts and commissions     (250,000)
Proceeds from notes payable - related party     59,000
Repayment of notes payable - related party     (231,901)
Net cash provided by financing activities   0 (231,901)
Net change in cash   (425,035) 317,874
Cash at beginning of period   619,576 2,774
Cash at end of period $ 320,648 194,541 320,648
Supplemental disclosure of non-cash financing activities:      
Offering costs included in accrued expenses, formation and offering costs   $ 0 1,521,318
Advisory fee     10,764,000
Deferred underwriting compensation     10,764,000
Offering costs charged to additional paid in capital     2,390,141
Initial classification of warrant liability - public     $ 1,524,900